About SensID
SensID is a Healthcare company based in Rostock (Germany) founded in 2015 by Bjorn Nowack, and was acquired by Microbiologics in November 2024. Reference materials for DNA diagnostic applications are developed. SensID offers products and services including gDNA Reference Standards, cfDNA / ctDNA, Plasma Reference Standards, and FFPE Reference Standards. Its focus areas include Life Sciences, Clinical Genomics, Amplification Based and PCR. Its legal entity is SensID GmbH.
Company details
SensID was founded in 2015 in Rostock, Germany, within the biotechnology sector. Reference materials, including tissue blocks and slides, are provided for DNA diagnostic uses such as RD, instrument validation, external controls, and quality control of diagnostic kits. These materials incorporate genetic modifications like point mutations, insertions, deletions, amplifications, and translocations in gDNA, cfDNA, and ctDNA. Compatibility is ensured with assays including FISH, immunohistochemistry, PCR, sequencing, and FACS.
- Headquarters Rostock, Germany
- Founders Bjorn Nowack
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website sens-id.com
- Social LinkedIn YouTube
- Acquired by Microbiologics (Nov 2024)
- Legal Name Sensid Gmbh
- InvestorsMicrobiologics
& 1 more
- Acquired byMicrobiologics
(Nov 2024)
Products & Services of SensID
SensID offers a comprehensive portfolio of products and services, including gDNA Reference Standards, cfDNA / ctDNA, Plasma Reference Standards, and FFPE Reference Standards.
Standards for genomic DNA analysis in diagnostics
Reference materials for circulating tumor DNA testing
Controls for liquid biopsy and DNA-free applications
Standards for tissue-based genomic analysis
Apps and channels of SensID
its YouTube channel SensID has 8 subscribers and 3 videos.
Videos from SensID
The most watched videos on SensID's YouTube channel, SensID (8 subscribers). Click a video to play it here.
More on SensID.
Funding Insights of SensID
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of SensID with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2018 | Series A | – | – |
2 investors in total: 2 institutional.
Investors in SensID
SensID has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Microbiologics and GENIUS Venture Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital is provided to technology startups in Mecklenburg-Vorpommern. | 1998 | genius-vc.de | Schwerin, Germany | |
Lyophilized quality control microorganisms are supplied for diverse industries. | 1971 | microbiologics.com | Saint Cloud, United States |
Investor details for SensID
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of SensID
1 people are tracked at SensID (1 in leadership).
| Name | Role | Group |
|---|---|---|
Bjorn Nowack | Co-Founder | Leadership |
Complete people profiles for SensID
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of SensID
3 dated milestones of SensID across 9 years, from founding to its latest funding, stage changes and deals.
- Founded SensID is founded.
- Funding First funding round.
- Exit Acquired by Microbiologics.
Web traffic of SensID
The website of SensID (sens-id.com) receives about 3.6K visits a month.
- Monthly visits3.6K
▲ 63.9% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sensid
Complete news archive for SensID
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SensID
SensID was founded in 2015 and raised its 1st funding round 3 years after it was founded.
SensID is headquartered in Rostock, Germany. It is registered at Rostock, Mecklenburg-vorpommern, Germany.
SensID was founded in 2015 in Rostock, Germany, within the biotechnology sector. Reference materials, including tissue blocks and slides, are provided for DNA diagnostic uses such as RD, instrument validation, external controls, and quality control of diagnostic kits. These materials incorporate genetic modifications like point mutations, insertions, deletions, amplifications, and translocations in gDNA, cfDNA, and ctDNA. Compatibility is ensured with assays including FISH, immunohistochemistry, PCR, sequencing, and FACS.
SensID offers gDNA Reference Standards, cfDNA / ctDNA, Plasma Reference Standards, and FFPE Reference Standards.
SensID has 2 investors. Key investors include Microbiologics, and GENIUS Venture Capital.
SensID operates through Sensid Gmbh.
Yes. SensID was acquired by Microbiologics in November 2024.